Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anders Forss"'
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 1 (2024)
Background There is some evidence of a higher prevalence of coeliac disease (CD) among patients with SLE than in the general population. However, the prevalence estimates vary substantially.Objective To investigate the prevalence of CD among patients
Externí odkaz:
https://doaj.org/article/aa9e997a5c2548b887877ee7b3c63d87
Autor:
Jiangwei Sun, Bjorn Roelstraete, Emma Svennberg, Jonas Halfvarson, Johan Sundström, Anders Forss, Ola Olén, Jonas F Ludvigsson
Publikováno v:
PLoS Medicine, Vol 20, Iss 10, p e1004305 (2023)
BackgroundAlthough previous evidence has suggested an increased risk of cardiovascular disease (CVD) in patients with inflammatory bowel disease (IBD), its association with arrhythmias is inconclusive. In this study, we aimed to explore the long-term
Externí odkaz:
https://doaj.org/article/037ef4fc0f9b4dd68fb57774f1006143
Autor:
Anders Forss, Pär Myrelid, Ola Olén, Åsa H. Everhov, Caroline Nordenvall, Jonas Halfvarson, Jonas F. Ludvigsson
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background About 50% of patients with Crohn’s disease (CD) and about 20% of those with ulcerative colitis (UC) undergo surgery at some point during the course of the disease. The diagnostic validity of the Swedish National Patient Register
Externí odkaz:
https://doaj.org/article/8ba870b8ab5c4bbb8f7dfc32dc888278
Autor:
Anders Forss, David Bergman, Bjorn Roelstraete, Johan Sundström, Ali Mahdi, Hamed Khalili, Jonas F. Ludvigsson
Publikováno v:
Clinical Gastroenterology and Hepatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54d6c74fcd712cccb44835fe461c558f
https://doi.org/10.1016/j.cgh.2023.05.014
https://doi.org/10.1016/j.cgh.2023.05.014
Publikováno v:
Gastroenterology. 164:1343-1344
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6151d1003ecd1dc1e5e938acc520d27
https://doi.org/10.1053/j.gastro.2022.10.015
https://doi.org/10.1053/j.gastro.2022.10.015
Publikováno v:
Gastroenterology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::416f16a09a4da53fe58c178dfab33357
https://pubmed.ncbi.nlm.nih.gov/36279924
https://pubmed.ncbi.nlm.nih.gov/36279924
Autor:
Charlotte Soderman, Mark Clements, Pär Myrelid, Agnieszka Wagner, David Andersson, Hans Strid, Anders Forss, Fredrik Hjelm, Jonas F. Ludvigsson, Jonas Halfvarson, Ola Olén
Publikováno v:
Scandinavian Journal of Gastroenterology. 56:680-686
Background Prospectively and systematically collected real-world data on the effectiveness of ustekinumab (anti-interleukin-12/23) for treating Crohns disease (CD) are still limited. Aim To assess the short-term real-world effectiveness of ustekinuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab574e4a25239d2881c3329133f005aa
https://doi.org/10.1080/00365521.2021.1906946
https://doi.org/10.1080/00365521.2021.1906946
Autor:
John B. Doyle, Benjamin Lebwohl, Johan Askling, Anders Forss, Peter H.R. Green, Bjorn Roelstraete, Jonas Söderling, Jonas F. Ludvigsson
Publikováno v:
The American journal of gastroenterology. 117(12)
Celiac disease (CD) is associated with many immune-mediated conditions, but a definitive epidemiological association between CD and juvenile idiopathic arthritis (JIA) or rheumatoid arthritis (RA) has not been established. We quantified the risk of J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8011bc383f4341e553dc0bdd2aa9be
https://pubmed.ncbi.nlm.nih.gov/36114769
https://pubmed.ncbi.nlm.nih.gov/36114769
Autor:
Joel, Thunberg, Olle, Björkqvist, Charlotte R H, Hedin, Anders, Forss, Charlotte, Söderman, Daniel, Bergemalm, Ola, Olén, Henrik, Hjortswang, Hans, Strid, Jonas F, Ludvigsson, Carl, Eriksson, Jonas, Halfvarson
Publikováno v:
United European gastroenterology journal. 10(7)
Background Real-world data on clinical outcomes of ustekinumab in ulcerative colitis are lacking. Objective To assess short- and long-term clinical outcomes of ustekinumab in ulcerative colitis. Methods Adult ulcerative colitis patients without previ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d446211f4867d563ca524b0068aaeb70
https://pubmed.ncbi.nlm.nih.gov/35841129
https://pubmed.ncbi.nlm.nih.gov/35841129
Autor:
Anders, Forss, Mark, Clements, Pär, Myrelid, Hans, Strid, Charlotte, Söderman, Agnieszka, Wagner, David, Andersson, Fredrik, Hjelm, Ola, Olén, Jonas, Halfvarson, Jonas F, Ludvigsson
Publikováno v:
Digestive diseases and sciences.
Prospectively and systematically collected long-term real-world clinical data on ustekinumab (anti-interleukin-12/23) are still scarce.To assess the long-term effectiveness of ustekinumab in patients with active Crohn's disease (CD).This is a prospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22a1a01d6922ab3f76dfd7957051452b
https://pubmed.ncbi.nlm.nih.gov/35459973
https://pubmed.ncbi.nlm.nih.gov/35459973